Citation Impact
Citing Papers
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
De novo design of transmembrane β barrels
2021 StandoutScienceNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Membrane Vesicles: an Overlooked Component of the Matrices of Biofilms
2006
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
1998 Standout
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Early Role of CD4+ Th1 Cells and Antibodies in HER-2 Adenovirus Vaccine Protection against Autochthonous Mammary Carcinomas
2005
Role of the lipid bilayer in outer membrane protein folding in Gram-negative bacteria
2020
Therapeutic potential of complement modulation
2009
Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context
2006 StandoutNobel
Myeloid-derived suppressor cells coming of age
2018 Standout
Crystal Structure of the HSV-1 Fc Receptor Bound to Fc Reveals a Mechanism for Antibody Bipolar Bridging
2006 StandoutNobel
Serogroup B meningococcal vaccines—an unfinished story
2010
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection
2016
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Human Antibody Effector Function
1992
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018 StandoutNobel
IgE and mast cells in allergic disease
2012 Standout
Relevance of Fcγ Receptor and Interleukin‐10 Polymorphisms for Meningococcal Disease
2001
Complement in human diseases: Lessons from complement deficiencies
2009
An overview of tissue and whole organ decellularization processes
2011 Standout
Human Umbilical Vein Endothelial Cells Synthesize Functional C3, C5, C6, C8 and C9 In Vitro
1991
IgG4-Related Disease
2012 Standout
T cells from the small intestinal Mucosa of a DR4, DQ7/DR4. DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8
1994
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Fcγ receptors as regulators of immune responses
2007 Standout
Contrasting IgG Structures Reveal Extreme Asymmetry and Flexibility
2002
IgG4 breaking the rules
2002
Biofilms: an emergent form of bacterial life
2016 Standout
Multifaceted roles of extracellular DNA in bacterial physiology
2015
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
The biofilm matrix
2010 Standout
Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae
2014
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
2009
Structure and function of immunoglobulins
2010
Hotspot-Centric De Novo Design of Protein Binders
2011 StandoutNobel
Building Antibodies from their Genes
1992 StandoutNobel
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood
2016
Role of C5a???C5aR Interaction in Sepsis
2003
Meningococcal Disease
2001
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
2010 StandoutNobel
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
IgG4-related disease
2014 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
The structural requirements for complement activation by IgG: does it hinge on the hinge?
1995
Anti-allergic properties of a new all-D synthetic immunoglobulin-binding peptide
2007
Phagocytosis: measurement by flow cytometry
2000
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens
2006
Exosomes: Therapy delivery tools and biomarkers of diseases
2017
Immunity to fungal infections
2011 Standout
Humanized antibodies
1993 StandoutNobel
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Cancer vaccines and carbohydrate epitopes
2011
FcRn: the neonatal Fc receptor comes of age
2007 Standout
Experimental and Computational Analyses of the Energetic Basis for Dual Recognition of Immunity Proteins by Colicin Endonucleases
2008 StandoutNobel
Complement recruitment using bispecific diabodies
1997 StandoutNobel
The immunoglobulin constant region contributes to affinity and specificity
2008
Bacterial Outer Membrane Vesicles and Vaccine Applications
2014
Immune response to biologic scaffold materials
2008
Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria
2022
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.
1993
ROLE OF C5A IN INFLAMMATORY RESPONSES
2005
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
StreptococcusAdherence and Colonization
2009
Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine
2010
Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria
2014
Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice
2003
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
The role of C5a in acute lung injury induced by highly pathogenic viral infections
2015
p38 and Src-ERK1/2 Pathways Regulate Crystalline Silica-Induced Chemokine Release in Pulmonary Epithelial Cells
2004
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
2010
Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies
1997
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
In Vitro Antibodies: Strategies for Production and Application
1992
Mechanism of Immunoglobulin G4 Fab-arm Exchange
2011
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Antibody Avidity and Immunoglobulin G Isotype Distribution following Immunization with a Monovalent Meningococcal B Outer Membrane Vesicle Vaccine
2002
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc
2000
Lipopolysaccharide Endotoxins
2002 Standout
Plastic and Human Health: A Micro Issue?
2017 Standout
Fine particles that adsorb lipopolysaccharide via bridging calcium cations may mimic bacterial pathogenicity towards cells.
2007
The oral microbiota: dynamic communities and host interactions
2018 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Proteomic Analysis and Immunogenicity of Mannheimia haemolytica Vesicles
2012
A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans
1996
Functions of the complement components C3 and C5 during sepsis
2008
Reconfigurable asymmetric protein assemblies through implicit negative design
2022 StandoutScienceNobel
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
2001 Science
Mycobacterial Membrane Vesicles Administered Systemically in Mice Induce a Protective Immune Response to Surface Compartments of Mycobacterium tuberculosis
2014
Works of Audun Aase being referenced
Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7–8 years of age
2014
Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region
1992
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis
2005
Chimeric mouse human IgG3 antibodies with an IgG4‐like hinge region induce complement‐mediated lysis more efficiently than IgG3 with normal hing
1991
Opsonophagocytic Activity Induced by Chimeric Antibodies of the Four Human IgG Subclasses With or Without Help from Complement
1994
The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fcγ receptors, but the heavy chains must be disulfide bonded
1993
The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis
2004
C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids
1989
The surface-associated elongation factor Tu is concealed for antibody binding on viable pneumococci and meningococci
2008
The allergy adjuvant effect of particles – genetic factors influence antibody and cytokine responses
2005
Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration
1991
Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines
2013
The IgG Subclass Pattern of Complement Activation Depends on Epitope Density and Antibody and Complement Concentration
1989
Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease
2003
Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies with Strong Bactericidal Activity in Humans
1998
Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface
2006
Construction and Functional Activities of Chimeric Mouse-Human Immunoglobulin G and Immunoglobulin M Antibodies against theNeisseria meningitidisPorA P1.7 and P1.16 Epitopes
2003
Mechanism for uptake of silica particles by monocytic U937 cells
2000
Human T-Cell Responses after Vaccination with the Norwegian Group B Meningococcal Outer Membrane Vesicle Vaccine
1998
Protection by Natural Human Immunoglobulin M Antibody to Meningococcal Serogroup B Capsular Polysaccharide in the Infant Rat Protection Assay Is Independent of Complement-Mediated Bacterial Lysis
2005
Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines
2007
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
1998
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis
2003
Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine
1999
One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
1994
Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
2006
Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine
1995
Meningococcal Omp85 in Detergent‐Extracted Outer Membrane Vesicle Vaccines Induces High Levels of Non‐Functional Antibodies in Mice
2013
C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
1990
Binding properties and anti-bacterial activities of V-region identical, human IgG and IgM antibodies, against group B Neisseria meningitidis
2003
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.
1998
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions
2015